Clinical Researcher, bioMérieux, Inc., Quidel and Medscape
BIOGRAPHY
MAY 08, 2017 10:00 AM EDT
WEBINAR: CDC Evaluation of a 2-Tier Lyme Disease EIA Testing Method and Potential Diagnostic Significance
Speaker
Event Date & Time
DATE: May 8th, 2017
TIME: 10:00AM PT, 11:00AM MT, 12:00PM CT, 1:00PM ET
Abstract
This webinar will describe the potential diagnostic benefits of using the dissociated VIDAS Lyme IgM II and VIDAS Lyme IgG II assays in a 2-tier EIA approach versus the use of the standard EIA / western blot algorithm.
You May Also Like
OCT 02, 2024 | 7:30 AM
De novo gene synthesis and protein expression are established technologies that can give access to nearly any target DNA or protein sequence, allowing for engineering of biologics. In this p...
DEC 10, 2024 | 9:00 AM
To-date, proteomic analysis has been severely limited in scale and resolution. Analyzing protein samples using an intact, single-molecule approach holds th...
MAY 08, 2017 10:00 AM EDT
Share
WEBINAR: CDC Evaluation of a 2-Tier Lyme Disease EIA Testing Method and Potential Diagnostic Significance
Loading Comments...